Advertisement

Current Rheumatology Reports

, Volume 3, Issue 5, pp 453–458 | Cite as

Inflammatory conditions of the eye associated with rheumatic diseases

  • Natalie A. Afshari
  • Mehran A. Afshari
  • C. Stephen Foster
Article

Abstract

Ocular inflammation occurs in many patients with systemic rheumatic disease. The best examples are rheumatoid arthritis, juvenile rheumatoid arthritis, temporal arteritis, systemic lupus erythematosus, Wegener’s granulomatosis, polyarteritis nodosa, relapsing polychondritis, and Adamantiades-BehÇet’s disease. Ocular inflammation may precede the symptoms of the systemic disease and can be helpful in systemic diagnosis. After diagnosis, ocular inflammation can mark the severity of the systemic condition. Thus, prompt diagnosis and treatment of inflammatory conditions of the eye are warranted and may be sight- and life-saving.

Keywords

Systemic Lupus Erythematosus Uveitis Juvenile Rheumatoid Arthritis Anterior Uveitis Ocular Inflammation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Rothova A, Suttorp-van Schulten MS, Frits Treffers W, et al.:Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996, 80:332–336.PubMedCrossRefGoogle Scholar
  2. 2.
    Ellwein LB, Fletcher A, Negrel AD, Thulasiraj RD: Quality of life assessment in blindness prevention interventions. Int Ophthalmol Clin 1994, 18:263–268.Google Scholar
  3. 3.
    Vedot E, Barth E, Billet P: Epidemiology of uveitis: preliminary results of a prospective study in Savoy. In Uveitis Update. Edited by Sarri KM. Amsterdam: Elsevier; 1984:13.Google Scholar
  4. 4.
    Foster CS, O’Brien JM: Anterior uveitis. In Principles and Practice of Ophthalmology. Edited by Albert and Jakobiec. Philadelphia: WB Saunders; 1999:1198. This chapter describes disease entities, many of them rheumatologic, that lead to anterior uveitis.Google Scholar
  5. 5.
    Harper SL, Foster CS: The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin 1998, 38:1–19.PubMedCrossRefGoogle Scholar
  6. 6.
    Mody GM, Hill JC, Meyers OL: Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol 1988, 7:237.PubMedCrossRefGoogle Scholar
  7. 7.
    Alspaugh MA, Talal N, Tan EM: Differentiation and characterization of autoantibodies and their antigens in Sjogren’s syndrome. Arthritis Rheum 1976, 19:216–222.PubMedCrossRefGoogle Scholar
  8. 8.
    Moutsopoulos HM, Mann DL: Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979, 301:761.PubMedCrossRefGoogle Scholar
  9. 9.
    Williamson J: Incidence of eye disease in cases of connective tissue disease. Trans Ophthal Soc UK 1974, 94:742.PubMedGoogle Scholar
  10. 10.
    Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with rheumatoid arthritis and with other systemic immunemediated diseases. Ophthalmology 1994, 101:1281.Google Scholar
  11. 11.
    Watson PG, Hayreh SS: Scleritis and episcleritis. Br J Ophthalmol 1976, 60:163.PubMedCrossRefGoogle Scholar
  12. 12.
    Tauber J, Sainz de la Maza M: An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea 1990, 9:66.PubMedCrossRefGoogle Scholar
  13. 13.
    Messmer EM, Foster CS: Destructive corneal and scleral disease associated with rheumatoid arthritis. Cornea 1995, 14:408.PubMedCrossRefGoogle Scholar
  14. 14.
    Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000, 130:492. This paper provides an expert panel of physician recommendations of immunosuppressive drugs for treatment of patients with ocular inflammatory disorders. The side-effects and complications of corticosteroids support the rationale for immunosuppressive treatment. The treatment regimen with immunosuppressive agents should be individualized and the patients monitored regularly.PubMedCrossRefGoogle Scholar
  15. 15.
    Cassidy JT, Levinson JE: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986, 29:274.PubMedCrossRefGoogle Scholar
  16. 16.
    Chylack LT, Biengang DC: Ocular manifestations of juvenile rheumatoid arthritis. Am J Ophthalmol 1975, 79:1026.PubMedGoogle Scholar
  17. 17.
    Wolf MD, Lichter PR, Ragsdale CG: Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987, 94:1242.PubMedGoogle Scholar
  18. 18.
    Rosenberg AM, Oen KG: The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum 1986, 29:797.PubMedCrossRefGoogle Scholar
  19. 19.
    Southwood TR, Ryder CA: Ophthalmological screening in juvenile arthritis: should the frequency of screening be based on the risk of developing chronic iridocyclitis? Br J Rheumatol 1992, 31:633.PubMedCrossRefGoogle Scholar
  20. 20.
    Kanski JJ: Anterior uveitis in juvenile rheumatoid arthritis. Arch Ophthalmol 1977, 95:1794.PubMedGoogle Scholar
  21. 21.
    O’Brien JM, Albert DM: Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis. Rheum Dis Clin North Am 1989, 15:413.PubMedGoogle Scholar
  22. 22.
    Foster CS, Barrett F: Cataract development and cataract surgery in patients with juvenile rheumatoid arthritisassociated iridocyclitis. Ophthalmology 1993, 100:809–817.PubMedGoogle Scholar
  23. 23.
    Brewerton DA, Caffrey M: Acute anterior uveitis and HLA27. Lancet 1973, 2:994.CrossRefGoogle Scholar
  24. 24.
    Linssen A: B27+ disease versus B27-disease. Scand J Rheumatol 1990, 87:111.CrossRefGoogle Scholar
  25. 25.
    Nusenblatt RE, Whitcup SM, Palestine AG: Uveitis Fundaments and Clinical Practice. St Louis: Mosby; 1996:270–273.Google Scholar
  26. 26.
    Spaeth GL: Corneal staining in systemic lupus erythematosus. N Engl J Med 1967, 276:1168.PubMedCrossRefGoogle Scholar
  27. 27.
    Gold DH, Morris DH, Henkind P: Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972, 56:800.PubMedCrossRefGoogle Scholar
  28. 28.
    Stafford-Brady FJ: Lupus retinopathy: patterns, associations, and prognosis. Arthritis Rheum 1988, 31:1105.PubMedCrossRefGoogle Scholar
  29. 29.
    Foster CS: Systemic lupus erythematosus. In Principles and Practice of Ophthalmology. Edited by Albert and Jakobiec. Philadelphia: WB Saunders; 1999:4563. This chapter summarizes clinical findings of systemic lupus erythematosus and its ophthalmic findings in detail.Google Scholar
  30. 30.
    Kearns TP: Collagen and rheumatic diseases: ophthalmic aspects. In The Eye and Systemic Disease. Edited by Masolf FA. St Louis: Mosby; 1975:105.Google Scholar
  31. 31.
    Rynes RI, Mika P, Bartholomew LE: Development of giant cell (temporal) arteritis in a patient "adequately" treated for polymyalgia rheumatica. Ann Rheum Dis 1977, 36:88.PubMedCrossRefGoogle Scholar
  32. 32.
    Hollenhorst RW, Rown JR, Wagener HP, Shick RM: Neurologic aspects of temporal. Neurology 1960, 10:490.PubMedGoogle Scholar
  33. 33.
    Afshari NA, Afshari MA, Lessell S: Temporal arteritis. Int Ophthalmol Clin 2001, 41:151–158. This paper summarizes temporal arteritis and its ocular findings.PubMedCrossRefGoogle Scholar
  34. 34.
    Huston KA, Hunder FF, Lie JT, et al.: Temporal arteritis: a 25-year epidemiological, clinical and pathologic study. Ann Intern Med 1978, 8:162.Google Scholar
  35. 35.
    Bullen CL, Liesegang TJ, McDonald TJ, et al.: Ocular complications of Wegener’s granulomatosis. Ophthalmology 1983, 90:279.PubMedGoogle Scholar
  36. 36.
    Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983, 98:76–85.PubMedGoogle Scholar
  37. 37.
    Wise GN: Ocular periarteritis nodosa. Arch Ophthalmol 1952, 47:1–11.Google Scholar
  38. 38.
    Moore GJ, Sevel D: Corneo-scleral ulceration in periarteritis nodosa. Br J Ophthalmol 1966, 50:651–655.PubMedCrossRefGoogle Scholar
  39. 39.
    Purcell JJ, Birkenkamp R, Tsai CC: Conjunctival lesions in periarteritis nodosa. Arch Ophthalmol 1984, 102:736.PubMedGoogle Scholar
  40. 40.
    Dolan DL, Lemmon GB Jr, Teitelbaum SL: Relapsing polychondritis chondritis. Am J Med 1966, 41:285–299.PubMedCrossRefGoogle Scholar
  41. 41.
    Zeuner M, Straub RH, Rauh G, et al.: Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 1997, 24:96–101.PubMedGoogle Scholar
  42. 42.
    Isaak BL, Liesegang TJ, Michet CJ Jr: Ocular and systemic findings in relapsing polychondritis. Ophthalmology 1986, 93:681–689.PubMedGoogle Scholar
  43. 43.
    Messmer EM, Foster CS: Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999, 43:379–396. This paper describes in detail the clinical findings and management of vasculitic conditions such as rheumatoid arthritis, systemic lupus erythematosus, WG, RP, and PAN associated with peripheral ulcerative keratitis, as PUK may be the first sign of systemic necrotizing vasculitis.PubMedCrossRefGoogle Scholar
  44. 44.
    Bhisitkul RB, Foster CS: Diagnosis and ophthalmological features of BehÇet’s disease. Int Ophthalmol Clin 1996, 36:127.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Natalie A. Afshari
    • 1
  • Mehran A. Afshari
    • 1
  • C. Stephen Foster
    • 1
  1. 1.Massachusetts Eye and Ear InfirmaryHarvard Medical SchoolBostonUSA

Personalised recommendations